학술논문
121P PemiBil: Efficacy and safety of pemigatinib in advanced cholangiocarcinoma with FGFR2 fusions/rearrangements in real-world, results of multicentric French cohort from ACABI consortium
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S228-S228
Subject
Language
ISSN
0923-7534